In this study, we analyzed 21 blood test biomarkers with comparison of the seven machine learning methods to identify the optimal biomarker panel and machine learning methods for irAE prediction in a combined cohort from four retrospective, multi-center clinical trials, involving advanced NSCLC patients treated with the anti-PD-L1 atezolizumab. Here, CD274 is linked to non-small cell lung carcinoma.